Impact of Bone Mineral Density on Fracture Risk Assessment in RA

Exclusion Criteria

• •Patients with secondary causes of osteoporosis (e.g., hyperparathyroidism, Cushing's syndrome).
• •Use of medications affecting bone metabolism (e.g., glucocorticoids \>7.5 mg/day, bisphosphonates, denosumab) within the past year.
• •History of metabolic bone diseases other than osteoporosis (e.g., osteomalacia, Paget's disease).
• •Patients with a history of malignancy, except for non-melanoma skin cancer.
• •Incomplete or missing data required for FRAX or DXA analysis.
• •Any condition or comorbidity likely to affect fracture risk assessment, as determined by the clinician.